Towards pain-free diagnosis of skin diseases through multiplexed microneedles: biomarker extraction and detection using a highly sensitive blotting method

Drug Delivery and Translational Research

Volumn 5, Issue 4, 2015, Pages 387-396

  Ng, Keng Wooi ^a   Lau, Wing Man ^b   Williams, Adrian C ^b  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Biomarkers; Densitometry; Immobilised antibody; Immunodiagnostic microneedles; Microprojection arrays; Skin diagnosis

Indexed keywords

ANTIBODY; ANTIGEN; BIOLOGICAL MARKER; IMMOBILIZED ANTIBODY; INTERLEUKIN 1ALPHA; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; BLOTTING; CONTROLLED STUDY; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNODIAGNOSTIC MICRONEEDLE; LIMIT OF DETECTION; MICRONEEDLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; SIGNAL DETECTION; SKIN DISEASE; ANIMAL; DEVICES; DIAGNOSTIC EQUIPMENT; ENZYME IMMUNOASSAY; EQUIPMENT DESIGN; HUMAN; IMMUNOLOGICAL PROCEDURES; METABOLISM; MICROINJECTION; NEEDLE; PROCEDURES; SKIN DISEASES;

ANIMALS; ANTIBODIES, IMMOBILIZED; BIOMARKERS; DIAGNOSTIC EQUIPMENT; EQUIPMENT DESIGN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOLOGIC TESTS; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; MICE; MICROINJECTIONS; NEEDLES; SKIN DISEASES;

EID: 84938816514     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-015-0231-5     Document Type: Article

References (29)

1. Gremel G, Grannas K, Sutton LA, Pontén F, Zieba A. In situ protein detection for companion diagnostics. Front Oncol. 2013;3:271. doi:10.3389/fonc.2013.00271.
2. Fuertes L, Santonja C, Kutzner H, Requena L. Immunohistochemistry in dermatopathology: a review of the most commonly used antibodies (part I). Actas Dermosifiliogr. 2013;104:99–127.
3. Fuertes L, Santonja C, Kutzner H, Requena L. Immunohistochemistry in dermatopathology: a review of the most commonly used antibodies (part II). Actas Dermosifiliogr. 2013;104:181–203.
4. Ericsson C, Nistér M. Protein extraction from solid tissue. Methods Mol Biol Clifton NJ. 2011;675:307–12. doi:10.1007/978-1-59745-423-0_17.
5. Skehel JM. Preparation of extracts from animal tissues. In: Cutler P, editor. Protein purification protocols. 2nd ed. Totowa: Humana Press; 2004. p. 15–20.
6. Kim Y-C, Park J-H, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64:1547–68. doi:10.1016/j.addr.2012.04.005.
7. Tuan-Mahmood T-M, McCrudden MTC, Torrisi BM, McAlister E, Garland MJ, Singh TRR, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013;50:623–37. doi:10.1016/j.ejps.2013.05.005.
8. Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24:585–94. doi:10.1097/AJP.0b013e31816778f9.
9. Haq MI, Smith E, John DN, Kalavala M, Edwards C, Anstey A, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices. 2009;11:35–47. doi:10.1007/s10544-008-9208-1.
10. Bhargav A, Muller DA, Kendall MAF, Corrie SR. Surface modifications of microprojection arrays for improved biomarker capture in the skin of live mice. ACS Appl Mater Interfaces. 2012;4:2483–9. doi:10.1021/am3001727.
11. Coffey JW, Corrie SR, Kendall MAF. Early circulating biomarker detection using a wearable microprojection array skin patch. Biomaterials. 2013;34:9572–83. doi:10.1016/j.biomaterials.2013.08.078.
12. Lee KT, Muller DA, Coffey JW, Robinson KJ, McCarthy JS, Kendall MAF, et al. Capture of the circulating plasmodium falciparum biomarker HRP2 in a multiplexed format, via a wearable skin patch. Anal Chem. 2014;86:10474–83. doi:10.1021/ac5031682.
13. Yeow B, Coffey JW, Muller DA, Grøndahl L, Kendall MAF, Corrie SR. Surface modification and characterization of polycarbonate microdevices for capture of circulating biomarkers, both in vitro and in vivo. Anal Chem. 2013;85:10196–204. doi:10.1021/ac402942x.
14. Muller DA, Corrie SR, Coffey J, Young PR, Kendall MA. Surface modified microprojection arrays for the selective extraction of the dengue virus NS1 protein as a marker for disease. Anal Chem. 2012;84:3262–8. doi:10.1021/ac2034387.
15. Corrie SR, Fernando GJP, Crichton ML, Brunck MEG, Anderson CD, Kendall MAF. Surface-modified microprojection arrays for intradermal biomarker capture, with low non-specific protein binding. Lab Chip. 2010;10:2655. doi:10.1039/c0lc00068j.
16. Strambini LM, Longo A, Diligenti A, Barillaro G. A minimally invasive microchip for transdermal injection/sampling applications. Lab Chip. 2012;12:3370. doi:10.1039/c2lc40348j.
17. Li CG, Lee CY, Lee K, Jung H. An optimized hollow microneedle for minimally invasive blood extraction. Biomed Microdevices. 2013;15:17–25. doi:10.1007/s10544-012-9683-2.
18. Strambini LM, Longo A, Scarano S, Prescimone T, Palchetti I, Minunni M, et al. Self-powered microneedle-based biosensors for pain-free high-accuracy measurement of glycaemia in interstitial fluid. Biosens Bioelectron. 2015;66:162–8. doi:10.1016/j.bios.2014.11.010.
19. Romanyuk AV, Zvezdin VN, Samant P, Grenader MI, Zemlyanova M, Prausnitz MR. Collection of analytes from microneedle patches. Anal Chem. 2014;86:10520–3. doi:10.1021/ac503823p.
20. Donnelly RF, Mooney K, Caffarel-Salvador E, Torrisi BM, Eltayib E, McElnay JC. Microneedle-mediated minimally invasive patient monitoring. Ther Drug Monit. 2014;36:10–7. doi:10.1097/FTD.0000000000000022.
21. McAllister DV, Wang PM, Davis SP, Park J-H, Canatella PJ, Allen MG, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A. 2003;100:13755–60. doi:10.1073/pnas.2331316100.
22. Zhu Y, Gao C, Liu X, Shen J. Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. Biomacromolecules. 2002;3:1312–9.
23. Cai N, Gong Y, Chian KS, Chan V, Liao K. Adhesion dynamics of porcine esophageal fibroblasts on extracellular matrix protein-functionalized poly(lactic acid). Biomed Mater. 2008;3:015014. doi:10.1088/1748-6041/3/1/015014.
24. Ansari AA, Hattikudur NS, Joshi SR, Medeira MA. ELISA solid phase: stability and binding characteristics. J Immunol Methods. 1985;84:117–24. doi:10.1016/0022-1759(85)90420-X.
25. Schramm W, Yang T, Midgley AR. Monoclonal antibodies used in solid-phase and liquid-phase assays, as exemplified by progesterone assay. Clin Chem. 1987;33:1331–7.
26. Lakowicz JR. Principles of fluorescence spectroscopy. Boston: Springer US; 2006. p. 277–330.
27. Shaner NC, Steinbach PA, Tsien RY. A guide to choosing fluorescent proteins. Nat Methods. 2005;2:905–9. doi:10.1038/nmeth819.
28. Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35:193–202. doi:10.1016/j.ejps.2008.06.016.
29. Del Pilar Martin M, Weldon WC, Zarnitsyn VG, Koutsonanos DG, Akbari H, Skountzou I, et al. Local response to microneedle-based influenza immunization in the skin. mBio. 2012;3:e00012–12. doi:10.1128/mBio.00012-12.